Merck Budva Expert Meeting
The “Let’s Change the Paradigm of Treatment of Cancer Patients” expert meeting, organized by Merck, is set to be a groundbreaking event in oncology. This meeting will spotlight the latest advancements and clinical experiences with Bavencio (avelumab) and Erbitux (cetuximab), two of Merck’s leading cancer therapies. Renowned oncologists and researchers will gather to discuss innovative approaches and emerging data on these treatments, aiming to enhance the therapeutic landscape for cancer patients.
Key topics will include the efficacy and safety profiles of Bavencio and Erbitux, their roles in combination therapies, and strategies to personalize cancer treatment. Attendees will benefit from in-depth presentations, case studies, and interactive discussions designed to foster collaboration and knowledge exchange. By focusing on these cutting-edge therapies, the meeting aims to shift the current paradigms in cancer treatment, ultimately improving patient outcomes and advancing the field of oncology.
Organizing a medical hybrid expert meeting, combining live and Zoom formats, involves several key tasks to ensure a successful event. The event agency starts by collaborating with the client to define the meeting’s objectives, themes, and target audience. They select a suitable venue equipped with necessary audiovisual technology to support both in-person and virtual participants. The agency coordinates the setup of live streaming and video conferencing tools, ensuring seamless integration and high-quality connections. They manage logistics including speaker arrangements, invitations, travel, and accommodations for in-person attendees. Preparation of materials such as agendas, presentation slides, and digital handouts is also crucial. Marketing efforts include promoting the event through various channels and managing registrations for both live and virtual attendees. On the day of the meeting, the agency oversees the event schedule, handles technical support, and facilitates interaction between live and online participants. Post-event, they gather feedback, analyze engagement metrics, and provide insights for future improvements.
Merck, a global leader in healthcare and life sciences, is dedicated to improving patient lives through innovative research, groundbreaking therapies, and a commitment to scientific excellence. With a rich history spanning over a century, Merck has consistently pushed the boundaries of medical science, delivering transformative treatments and solutions across a wide range of therapeutic areas, including oncology, immunology, and cardiology.
Merck’s mission is driven by a relentless focus on discovering and developing medicines and vaccines that address unmet medical needs. Their portfolio includes pioneering drugs like Keytruda (pembrolizumab), Bavencio (avelumab), and Erbitux (cetuximab), which have significantly impacted patient care and outcomes globally. Beyond pharmaceuticals, Merck is also a leader in life sciences, providing cutting-edge tools and technologies for research and biomanufacturing.
Committed to corporate responsibility, Merck invests in sustainable practices, education, and access to healthcare, striving to create a healthier and more equitable world. Through continuous innovation and collaboration, Merck remains at the forefront of advancing medical science and improving global health.
